An observational study in Humeral Fracture, Proximal, sponsored by Peking University People's Hospital. Status unknown. Open to participants aged 60 Years to 85 Years. Per ClinicalTrials.gov, last updated 2017-12-02.
Sponsored by Peking University People's Hospital · Observational
To explore clinical effectiveness of PHILOS plate fixation and hemi-shoulder arthroplasty in treating three or four-part fractures of proximal humerus
From April 2015 and April 2017, patients from multi-center aged over 60 years old with three and four-part fractures of proximal humerus were treated with Proximal Humerus Internal Locking System(PHILOS) and hemi-shoulder arthroplasty in multi-center. All the patients received the same rehabilitation course. At 6 months after surgery, postoperative complications were observed, EQ-5D was used to evaluate quality of life, and ASES score was used to assess functional outcomes.
patients with three or four part fractures of proximal humerus, who agreed to receive surgery.
three or four part fractures of proximal humerus
Exclusion Criteria:
three or four-part fractures of proximal humerus treated with internal fixation
Procedure: PHILOS Plate
three or four-part fractures of proximal humerus treated with hemi-shoulder arthroplasty
Procedure: Hemi-shoulder Arthroplasty
Hemi-shoulder Arthroplasty treating three or four-part fractures of proximal humerus
PHILOS plate treating three or four-part fractures of proximal humerus
Postoperative complications
Postoperative complications were observed
Time frame: 6 months after surgery
EQ-5D
EQ-5D was used to evaluate quality of life
Time frame: 6 months after surgery
ASES score
ASES was used to assess functional outcomes
Time frame: 6 months after surgery
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking University People's Hospital